Skip to main content
logo
Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.780
-0.130 (-6.81%)
At close: Mar 27, 2026, 4:00 PM EDT
1.770
-0.010 (-0.56%)
After-hours: Mar 27, 2026, 7:57 PM EDT

Caribou Biosciences Revenue

In the year 2025, Caribou Biosciences had annual revenue of $11.16M with 11.66% growth. Caribou Biosciences had revenue of $3.94M in the quarter ending December 31, 2025, with 89.74% growth.

Revenue (ttm)
$11.16M
Revenue Growth
+11.66%
P/S Ratio
15.41
Revenue / Employee
$115,041
Employees
97
Market Cap
172.01M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202511.16M1.17M11.66%
Dec 31, 20249.99M-24.48M-71.01%
Dec 31, 202334.48M20.63M148.91%
Dec 31, 202213.85M4.25M44.31%
Dec 31, 20219.60M-2.76M-22.35%
Dec 31, 202012.36M6.57M113.56%
Dec 31, 20195.79M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Compugen72.76M
Protalix BioTherapeutics52.74M
Fennec Pharmaceuticals44.64M
Zentalis Pharmaceuticals26.87M
Whitehawk Therapeutics7.15M
Connect Biopharma Holdings762.00K
SAB Biotherapeutics114.70K
Adagene103.20K
Revenue Rankings

CRBU News

More News